Related Experiment Videos

Tolerance to viral antigens in Mov-13 mice carrying endogenized Moloney-murine leukemia virus

Cellular Immunology
|February 1, 1984
PubMed

Insights

Early Moloney-murine leukemia virus (M-MuLV) activation in virus-positive (V+) mice induces immune tolerance. This tolerance affects both antibody production and cytotoxic T lymphocyte responses, contributing to T-cell lymphomas.

Area of Science:

  • Immunology
  • Virology
  • Genetics

Background:

  • Moloney-murine leukemia virus (M-MuLV) is integrated into the germ line of C57BL/6 Mov-13 mice.
  • Viral antigens are expressed early in lymphoid and nonlymphoid organs of virus-positive (V+) mice.

Purpose of the Study:

  • To investigate the immune reactivity to viral antigens in M-MuLV-infected mice.
  • To compare immune responses in virus-positive (V+) and virus-negative (V-) Mov-13 mice.

Main Methods:

  • Radioimmuno-binding and -precipitation assays were used to detect antibody production.
  • Secondary mixed-leukocyte tumor cell culture (MLTC) was employed to assess cytotoxic T lymphocyte (CTL) responses.
  • In vivo and in vitro stimulation assays were performed to evaluate CTL precursor frequency.

Main Results:

  • Virus-negative (V-) mice produced antibodies after Moloney-murine sarcoma virus (M-MSV) challenge, while V+ mice did not.
  • V+ mice failed to generate virus-specific CTLs in MLTC, unlike V- mice which showed a strong response.
  • A very low frequency of CTL precursors in V+ mice did not increase upon M-MSV challenge or MBL-2 cell line stimulation.

Conclusions:

  • Early M-MuLV activation in Mov-13 V+ mice induces immune tolerance to viral antigens.
  • This tolerance encompasses both humoral and cellular immune responses.
  • The observed immune tolerance is linked to the high incidence of T-cell lymphomas in these mice.

Related Concept Videos